BIVI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

BioVie Insider Trading History Chart

BioVie Share Price & Price History

^$1.35

▼ -0.09 (-6.25%)

As of 04/10/2026 05:00 PM ET

Days: 30 | 90 | 365

BioVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/30/2023	Cuong V Do	CEO	Buy	1,000	$17.80	$17,800.00	6,875
9/5/2023	Steve Gorlin	Director	Sell	856	$30.50	$26,108.00	7,568
8/22/2023	Richard J Berman	Director	Sell	1,080	$35.00	$37,800.00	1,678
6/7/2023	Richard J Berman	Director	Sell	598	$58.10	$34,743.80	2,321
5/22/2023	Richard J Berman	Director	Sell	500	$65.00	$32,500.00	2,919

SEC Filings (Institutional Ownership Changes) for BioVie (NASDAQ:BIVI)

4.59% of BioVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/18/2026	XTX Topco Ltd	21,635	$25K	0.0%	N/A	0.287%
2/12/2026	DRW Securities LLC	128,356	$0.15M	0.0%	N/A	1.701%
2/12/2026	Renaissance Technologies LLC	28,018	$33K	0.0%	-61.6%	0.371%
11/17/2025	Prosperity Wealth Management Inc.	143,500	$0.27M	0.1%	N/A	1.903%
11/17/2025	Prelude Capital Management LLC	144,762	$0.28M	0.0%	N/A	1.920%
11/17/2025	Citadel Advisors LLC	104,531	$0.20M	0.0%	N/A	1.386%
11/14/2025	Two Sigma Investments LP	32,505	$62K	0.0%	N/A	0.431%
11/14/2025	Squarepoint Ops LLC	33,294	$63K	0.0%	N/A	0.442%
8/14/2025	Jane Street Group LLC	61,742	$57K	0.0%	N/A	3.319%
8/12/2025	XTX Topco Ltd	43,307	$40K	0.0%	N/A	2.328%
5/16/2025	NewEdge Advisors LLC	54,100	$53K	0.0%	+283.7%	0.293%
2/17/2025	Squarepoint Ops LLC	14,213	$28K	0.0%	N/A	0.080%
2/17/2025	Two Sigma Investments LP	28,713	$57K	0.0%	N/A	0.162%
2/17/2025	Millennium Management LLC	122,619	$0.25M	0.0%	N/A	0.690%
2/14/2025	Northern Trust Corp	16,878	$34K	0.0%	N/A	0.095%
2/13/2025	NewEdge Advisors LLC	14,100	$28K	0.0%	+14,000.0%	0.079%
2/13/2025	Bank of Montreal Can	50,000	$100K	0.0%	N/A	0.281%
2/12/2025	Geode Capital Management LLC	123,408	$0.25M	0.0%	+223.3%	0.694%
2/7/2025	Prosperity Wealth Management Inc.	31,650	$63K	0.0%	N/A	0.178%
1/22/2025	Drive Wealth Management LLC	60,000	$0.12M	0.0%	N/A	0.338%
1/15/2025	Sanders Morris Harris LLC	40,000	$85K	0.0%	N/A	0.225%
5/14/2024	Sheaff Brock Investment Advisors LLC	51,400	$27K	0.0%	+276.9%	0.129%
5/7/2024	CVI Holdings LLC	599,897	$0.32M	0.3%	N/A	1.503%
11/7/2023	Jump Financial LLC	10,000	$34K	0.0%	N/A	0.027%
10/30/2023	Summit Trail Advisors LLC	10,100	$34K	0.0%	N/A	0.027%
10/25/2023	Crescent Grove Advisors LLC	11,000	$38K	0.0%	N/A	0.030%
10/24/2023	Bank of New York Mellon Corp	15,955	$54K	0.0%	-51.2%	0.043%
8/29/2023	Garde Capital Inc.	24,163	$0.10M	0.0%	+40.8%	0.066%
7/20/2023	AJ Wealth Strategies LLC	23,474	$0.10M	0.0%	+52.2%	0.065%
7/11/2023	FNY Investment Advisers LLC	8,986	$38K	0.0%	N/A	0.025%
5/4/2023	Barclays PLC	54,117	$0.44M	0.0%	+117.7%	0.150%
4/28/2023	AJ Wealth Strategies LLC	15,428	$0.13M	0.0%	N/A	0.043%
2/24/2023	Garde Capital Inc.	17,163	$0.13M	0.0%	N/A	0.049%
2/14/2023	683 Capital Management LLC	16,110	$0.13M	0.0%	N/A	0.053%
2/14/2023	swisspartners Ltd.	294,346	$2.29M	2.9%	+82.8%	0.964%
2/7/2023	Commonwealth Equity Services LLC	12,175	$94K	0.0%	N/A	0.040%
2/1/2023	Bank of Montreal Can	10,000	$78K	0.0%	N/A	0.033%
1/30/2023	International Assets Investment Management LLC	10,500	$82K	0.0%	N/A	0.034%
1/10/2023	FNY Investment Advisers LLC	14,200	$0.11M	0.2%	N/A	0.047%
11/15/2022	Pura Vida Investments LLC	36,617	$91K	0.0%	N/A	0.120%
5/4/2022	swisspartners Ltd.	10,367	$1.87M	1.3%	-87.1%	0.042%
2/14/2022	Long Focus Capital Management LLC	20,000	$90K	0.0%	N/A	0.080%

Data available starting January 2016

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Today's Range

Now: $1.35

$1.35

$1.49

50 Day Range

MA: $1.32

$1.06

$1.49

52 Week Range

Now: $1.35

$1.06

$13.20

Volume

39,116 shs

Average Volume

62,749 shs

Market Capitalization

$10.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Who are the company insiders with the largest holdings of BioVie?: BioVie's top insider investors include:
Steve Gorlin (Director)
Cuong V Do (CEO)
Richard J Berman (Director)
Joanne Wendy Kim (CFO)
Learn More about top insider investors at BioVie.